LIPID METABOLISM DISORDERS AND ITS CORRECTION IN CHRONIC KIDNEY DISEASE
Abdullayev Ikrom AbduvaliyevichBukhara state medical institute, Bukhara, Uzbekistan
ABI
Abstract
Abstract. Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipidmodifying drugs — statins, fibrates, nicotinic acid was proposed.
Topics
Identifiers
Citations and references
Cited by 00 references